DexCom, a global leader in glucose biosensing systems, stands out for its innovative continuous glucose monitoring (CGM) ...

Detailed price information for American Diversified Holdings Corp (ADHC) from The Globe and Mail including charting and ...

In earnings calls, diabetes tech companies had less to say about tariffs and focused more on future growth.

Ken Griffin, the founder of Citadel, is an influential albeit controversial figure in the investment industry.

In addition to improved accuracy, the Dexcom G7 15 Day allows for 15.5 days of wear. The Food and Drug Administration (FDA) has cleared the Dexcom G7 15 Day continuous glucose monitoring (CGM ...

Apple Watches are more than just feature-packed wearables; they're important tools for monitoring our health, including our heart rate, sleep patterns, and cardio fitness. Even if you don't know ...

DexCom, Inc. DXCM recently announced the FDA clearance for its 15-day wear G7 Continuous Glucose Monitoring (CGM) system, the longest-lasting and most accurate CGM approved in the United States.

The US Food and Drug Administration has cleared the Dexcom G7 15-Day Continuous Glucose Monitor (CGM) for people older than 18 with diabetes. It's the longest-lasting system on the market.

She is also a Certified Stress Management Coach. The US Food and Drug Administration has cleared the Dexcom G7 15-Day Continuous Glucose Monitor (CGM) for people older than 18 with diabetes.

Credit: Dexcom. The Dexcom G7 15 Day CGM system is a wearable sensor that continuously measures glucose levels and transmits readings every 5 minutes with no fingersticks or scanning required.

The San Diego, Calif.-based firm said Thursday that its Dexcom G7 15 Day system had been approved by the FDA to treat people 18 and older with diabetes. It is expected to launch in the U.S. in the ...

The Dexcom G7 15 Day builds on the existing Dexcom CGM technology, which has been clinically demonstrated to improve diabetes management by lowering A1C levels and reducing the occurrence of both ...